Programme 2018

WEDNESDAY, 13 JUNE

17:30: Reception at the Skandion Clinic, Scandinavia’s first clinic for proton therapy, including a guided tour.

THURSDAY, 14 JUNE

08:00 Registration opens

09:00 Official opening

09:15 Plenum session 1: A Visionary Outlook

Session objective: This session will draw the broad picture of why this summit is neeeded; the challenges ahead, including those from an equity of access and economic perspective. It also serves to shed light on the many opportunities, for example in bio-banks, data and registries that can create a positive trajectory forward.

Speakers:

Dr. Susan Galbraith, Head of Oncology, iMed, Innovative Medicines, AstraZeneca
Professor Klas Kärre, Chairman, the Swedish Cancer Society’s research committee
Professor Max Parkin, Nuffield Dept. of Population Health, Oxford University

10:30 Coffeebreak, with delegate match-making

11:15 Workshops in parallel:

12:45 Lunch

13:45 Workshops continue

15:15 Coffeebreak, with delegate match-making

16:00 Plenum Session 2: Patients as a driving force to develop care

Speakers:

Gregory C. Simon J.D., President, Biden Cancer Initiative
Ingela Franck Lissbrant, MD, PhD, Sahlgrenska University Hospital and Swedish National Prostate Cancer Registry
Marie Ennis O'Connor, Patient Empowerment Foundation and Health Care Social Media.
Kelechi Eguzo, MD, MPH, Nigerian Christian Hospital; Chairman Marjorie Bash Foundation, Nigeria

Session objective: In many parts of the world, patients and their kin claim an individual relation to healthcare, focusing on the patient. Expectations are high on receiving an individualized treatment; on transparency and on access to your own data. Many also want to contribute to the development of cancer care with their own data, generated inside or outside healthcare.

How will this development influence the relationship between healthcare and the individual patient? How can healthcare take advantage of the research advancements in precision medicine? How should patients be involved? And is a patient focus only a high income luxury or a possibility everywhere?

17:10 Reports from workshops

19:00 Dinner

FRIDAY 15 JUNE

07:45 - 08:15 Optional morning walk in the Uppsala University Botanical Gardens. Meeting point by the gates at Dag Hammarsköldsväg - below the castle. See map in programme book.

08:45 Welcome back

09:00 Plenum session 3: Access to treatments and diagnostics

Session objective: Access to new cancer diagnostics and treatments is extremely unequally distributed, especially between high- and low income countries. Pharma industry has been strongly criticized for charging too much. But is it really that simple? Can we secure both access and an innovating industry?

Speakers:

Dr. Mariângela Simão, WHO, Assistant Director General
Professor Arnie Purushotham, King's College London and Tata Trust, Mumbai
Thomas B. Cueni, Director General, International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)

10:00 Coffeebreak, with delegate match-making

10:45 Workshops in parallel:

12:15 Lunch

13:15 Workshops continue

14:45 Coffeebreak

15:15 Plenum session 4: The threats against public health: Governance vs behavioural changes

Session objective: Lifestyle is responsible for 30 % of all cancer cases. Tobacco alone may explain 20 %. Is it responsible to lay the burden of changing lifestyle on the individual only? What can can international governance and politics achieve?

Speakers:

Dr. Vinayak Mohan Prasad, Programme Manager, Tobacco Control, WHO
Professor Mike Kelly, Institute of Public Health, University of Cambridge
Professor Emerita Barbro Westerholm, Member of Swedish Parliament
Professor Folke Tersman, Department of Philosophy, Uppsala University

16:25 Reports from workshops

16:55 Plenum Session 5 - Conclusions and take-home messages

A summarising dialogue with Programme Commmittee Chair Professor Emeritus Lars Holmberg and delegates.

17:15 Summit ends